BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20398728)

  • 1. Pituitary tumors: cell type-specific roles for BMP-4.
    Labeur M; Páez-Pereda M; Haedo M; Arzt E; Stalla GK
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):85-8. PubMed ID: 20398728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells.
    Miyoshi T; Otsuka F; Otani H; Inagaki K; Goto J; Yamashita M; Ogura T; Iwasaki Y; Makino H
    J Endocrinol; 2008 Apr; 197(1):159-69. PubMed ID: 18372242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action.
    Giacomini D; Páez-Pereda M; Theodoropoulou M; Labeur M; Refojo D; Gerez J; Chervin A; Berner S; Losa M; Buchfelder M; Renner U; Stalla GK; Arzt E
    Endocrinology; 2006 Jan; 147(1):247-56. PubMed ID: 16195406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of bone morphogenetic proteins in prolactin regulation by somatostatin analogs in rat pituitary GH3 cells.
    Tsukamoto N; Otsuka F; Miyoshi T; Inagaki K; Nakamura E; Suzuki J; Ogura T; Iwasaki Y; Makino H
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):163-9. PubMed ID: 20970474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP action in the pituitary: its possible role in modulating somatostatin sensitivity in pituitary tumor cells.
    Otsuka F; Tsukamoto N; Miyoshi T; Iwasaki Y; Makino H
    Mol Cell Endocrinol; 2012 Feb; 349(2):105-10. PubMed ID: 22056414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New mechanisms involved in the pathogenesis of pituitary adenomas].
    Giacomini D; Páez-Pereda M; Refojo D; Carbia Nagashima A; Chervin A; Goldberg V; Arzt E
    Medicina (B Aires); 2003; 63(2):147-50. PubMed ID: 12793085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bone morphogenetic protein (BMP) on adrenocorticotropin production by pituitary corticotrope cells: involvement of up-regulation of BMP receptor signaling by somatostatin analogs.
    Tsukamoto N; Otsuka F; Miyoshi T; Yamanaka R; Inagaki K; Yamashita M; Otani H; Takeda M; Suzuki J; Ogura T; Iwasaki Y; Makino H
    Endocrinology; 2010 Mar; 151(3):1129-41. PubMed ID: 20056821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follistatin, induced by thyrotropin-releasing hormone (TRH), plays no role in prolactin expression but affects gonadotropin FSHbeta expression as a paracrine factor in pituitary somatolactotroph GH3 cells.
    Oride A; Kanasaki H; Purwana IN; Mutiara S; Miyazaki K
    Regul Pept; 2009 Aug; 156(1-3):65-71. PubMed ID: 19446581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.
    Paez-Pereda M; Giacomini D; Refojo D; Nagashima AC; Hopfner U; Grubler Y; Chervin A; Goldberg V; Goya R; Hentges ST; Low MJ; Holsboer F; Stalla GK; Arzt E
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1034-9. PubMed ID: 12552124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells.
    Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H
    J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary action of cytokines: focus on BMP-4 and gp130 family.
    Giacomini D; Acuña M; Gerez J; Nagashima AC; Silberstein S; Páez-Pereda M; Labeur M; Theodoropoulou M; Renner U; Stalla GK; Arzt E
    Neuroendocrinology; 2007; 85(2):94-100. PubMed ID: 17337883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
    Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotroph-lactotroph associations and expression of prolactin receptors in the equine pituitary gland throughout the seasonal reproductive cycle.
    Gregory SJ; Brooks J; McNeilly AS; Ingleton PM; Tortonese DJ
    J Reprod Fertil; 2000 Jul; 119(2):223-31. PubMed ID: 10864834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
    Glister C; Kemp CF; Knight PG
    Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-4 control of pituitary pathophysiology.
    Giacomini D; Páez-Pereda M; Theodoropoulou M; Gerez J; Nagashima AC; Chervin A; Berner S; Labeur M; Refojo D; Renner U; Stalla GK; Arzt E
    Front Horm Res; 2006; 35():22-31. PubMed ID: 16809920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin and somatostatin receptors in Cushing's disease.
    Hofland LJ
    Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
    Gruszka A; Kunert-Radek J; Pawlikowski M
    Neuro Endocrinol Lett; 2005 Feb; 26(1):51-4. PubMed ID: 15726020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic regulation of pituitary mRNAs for bone morphogenetic protein (BMP) 4, BMP receptors, and activin/inhibin subunits in the ewe during the estrous cycle and in cultured pituitary cells.
    Sallon C; Faure MO; Fontaine J; Taragnat C
    J Endocrinol; 2010 Oct; 207(1):55-65. PubMed ID: 20675306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
    Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
    Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.